Topical drug to Prevent Chemotherapy-Induced Neurotoxicity
Dermally applied inducers of P-glycoprotein to protect the patient's nerve cells from chemotherapy induced damage
- All intellectual property rights are owned by SDU.
- A PCT application was submitted in August 2020 (WO 2021/043673 A1).
- EP4025183A1 / P-gp inducers as protectors against chemotherapy-induced side effects, such as peripheral neuropathy (cipn) and hair loss
- Patent application submitted
- Seeking investment
- Development partner
- Commercial partner